Micro RNA-320 as a novel potential biomarker in renal ischemia reperfusion

References

• Varela CF, Greloni G, Schreck C, et al. Assessment of fractional excretion of urea for early diagnosis of cardiac surgery associated acute kidney injury. Ren Fail. 2015;37:327–331.
   PubMed Web of Science ®Google Scholar
• Wu HC, Lee LC, Wang WJ. Incidence and mortality of postoperative acute kidney injury in non-dialysis patients: Comparison between the AKIN and KDIGO criteria. Ren Fail. 2016;38:330–339.
   PubMed Web of Science ®Google Scholar
• Kline J, Rachoin JS. Acute kidney injury and chronic kidney disease: It's a two-way street. Ren Fail. 2013;35:452–455.
   PubMed Web of Science ®Google Scholar
• Kato M, Arce L, Natarajan R. MicroRNAs and their role in progressive kidney diseases. Clin J Am Soc Nephrol. 2009;4:1255–1266.
   PubMed Web of Science ®Google Scholar
• Hu H, Jiang W, Xi X, Zou C, Ye Z. MicroRNA-21 attenuates renal ischemia reperfusion injury via targeting caspase signaling in mice. Am J Nephrol. 2014;40:215–223.
   PubMed Web of Science ®Google Scholar
• Godwin JG, Ge X, Stephan K, Jurisch A, Tullius SG, Iacomini J. Identification of a microRNA signature of renal ischemia reperfusion injury. Proc Natl Acad Sci USA. 2010;107:14339–14344.
   PubMed Web of Science ®Google Scholar
• Nassirpour R, Mathur S, Gosink MM, et al. Identification of tubular injury microRNA biomarkers in urine: Comparison of next-generation sequencing and qPCR-based profiling platforms. BMC Genomics. 2014;15:485.
   PubMed Web of Science ®Google Scholar
• Altunoluk B, Soylemez H, Oguz F, Turkmen E, Fadillioglu E. An Angiotensin-converting enzyme inhibitor, zofenopril, prevents renal ischemia/reperfusion injury in rats. Ann Clin Lab Sci. 2006;36:326–332.
   PubMed Web of Science ®Google Scholar
• Vargas AV, Robinson AV, Schulak JA. Captopril amelioration of renal reperfusion injury. J Surg Res. 1994;57:28–32.
   PubMed Web of Science ®Google Scholar
• Scribner AW, Loscalzo J, Napoli C. The effect of angiotensin-converting enzyme inhibition on endothelial function and oxidant stress. Eur J Pharmacol. 2003;482:95–99.
   PubMed Web of Science ®Google Scholar
• Liu YH, You Y, Song T, Wu SJ, Liu LY. Impairment of endothelium-dependent relaxation of rat aortas by homocysteine thiolactone and attenuation by captopril. J Cardiovasc Pharmacol. 2007;50:155–161.
   PubMed Web of Science ®Google Scholar
• Ibrahim MA, Ashour OM, Ibrahim YF, El-Bitar HI, Gomaa W, Abdel-Rahim SR. Angiotensin-converting enzyme inhibition and angiotensin AT(1)-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity. Pharmacol Res. 2009;60:373–381.
   PubMed Web of Science ®Google Scholar
• Amirshahrokhi K, Ghazi-khansari M, Mohammadi-Farani A, Karimian G. Effect of captopril on TNF-α and IL-10 in the livers of bile duct ligated rats. Iran J Immunol. 2010;7:247–251.
   PubMed Web of Science ®Google Scholar
• Tsunenari I, Ohmura T, Seidler R, et al. Renoprotective effects of telmisartan in the 5/6 nephrectomised rats. J Renin Angiotensin Aldosterone Syst. 2007;8:93–100.
   PubMed Web of Science ®Google Scholar
• Cibulskyte D, Pedersen M, Hørlyck A, et al. Telmisartan attenuates chronic ciclosporin A nephrotoxicity in a pig model. Nephrol Dial Transplant. 2007;22:369–375.
   PubMed Web of Science ®Google Scholar
• Fouad AA, Qureshi HA, Al-Sultan AI, Yacoubi MT, Al-Melhim WN. Nephroprotective effect of telmisartan in rats with ischemia/reperfusion renal injury. Pharmacology. 2010;85:158–167.
   PubMed Web of Science ®Google Scholar
• Benson SC, Pershadsingh HA, Ho C, et al. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity . Hypertension. 2004;43:993–1002.
   PubMed Web of Science ®Google Scholar
• Cianchetti S, Del Fiorentino A, Colognato R, Di Stefano R, Franzoni F, Pedrinelli R. Antiinflammatory and anti-oxidant properties of telmisartan in cultured human umbilical vein endothelial cells. Atherosclerosis. 2008;198:22–28.
   PubMed Web of Science ®Google Scholar
• Fouad AA, Jresat I. Captopril and telmisartan treatments attenuate cadmium-induced testicular toxicity in rats. Fundam Clin Pharmacol. 2013;27:152–160.
   PubMed Web of Science ®Google Scholar
• Fouad AA, Al-Mulhim AS, Jresat I, Morsy MA. Protective effects of captopril in diabetic rats exposed to ischemia/reperfusion renal injury. J Pharm Pharmacol. 2013;65:243–252.
   PubMed Web of Science ®Google Scholar
• Kusunoki H, Taniyama Y, Azuma J, et al. Telmisartan exerts renoprotective actions via peroxisome proliferator-activated receptor-γ/hepatocyte growth factor pathway independent of angiotensin II type 1 receptor blockade. Hypertension. 2012;59:308–316.
   PubMed Web of Science ®Google Scholar
• Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem. 2004;37:112–119.
   PubMed Web of Science ®Google Scholar
• Eren Y, Dirik E, Neselioglu S, Erel O. Oxidative stress and decreased thiol level in patients with migraine: Cross-sectional study. Acta Neurol Belg. 2015;115:643–649.
   PubMed Web of Science ®Google Scholar
• Jablonski P, Howden BO, Rae DA, Birrell CS, Marshall VC, Tange J. An experimental model for assessment of renal recovery from warm ischemia. Transplantation. 1983;35:198–204.
   PubMed Web of Science ®Google Scholar
• Wei Q, Bhatt K, He HZ, Mi QS, Haase VH, Dong Z. Targeted deletion of Dicer from proximal tubules protects against renal ischemia-reperfusion injury. J Am Soc Nephrol. 2010;21:756–761.
   PubMed Web of Science ®Google Scholar
• Ye Y, Perez-Polo JR, Qian J, Birnbaum Y. The role of microRNA in modulating myocardial ischemia-reperfusion injury. Physiol Genomics. 2011;43:534–542.
   PubMed Web of Science ®Google Scholar
• Zhu H, Fan GC. Role of microRNAs in the reperfused myocardium towards post-infarct remodelling. Cardiovasc Res. 2012;94:284–292.
   PubMed Web of Science ®Google Scholar
• Degroot H, Rauen U. Ischemia-reperfusion injury: Processes in pathogenetic networks: A review. Transplant Proc. 2007;39:481–484.
   PubMed Web of Science ®Google Scholar
• Kulshreshtha R, Ferracin M, Wojcik SE, et al. A microRNA signature of hypoxia. Mol Cell Biol. 2006;27:1859–1867.
   PubMed Web of Science ®Google Scholar
• Kulshreshtha R, Davuluri RV, Calin GA, Ivan M. A microRNA component of the hypoxic response. Cell Death Differ. 2008;15:667–671.
   PubMed Web of Science ®Google Scholar
• Lorenzen JM, Kielstein JT, Hafer C. Circulating miR-210 predicts survival in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol. 2011;6:1540–1546.
   PubMed Web of Science ®Google Scholar
• Ren XP, Wu J, Wang X, et al. MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation. 2009;119:2357–2366.
   PubMed Web of Science ®Google Scholar
• Zeng L, Tan J, Hu Z, Lu W, Yang B. Hsp20 protects neuroblastoma cells from ischemia/reperfusion injury by inhibition of apoptosis via a mechanism that involves the mitochondrial pathways. Curr Neurovasc Res. 2010;7:281–287.
   PubMed Web of Science ®Google Scholar
• Pogue AI, Percy ME, Cui JG, et al. Upregulation of NF-kB-sensitive miRNA-125b and miRNA-146a in metal sulfate stressed human astroglial (HAG) primary cell cultures. J Inorg Biochem. 2011;105:1434–1437. 2011.
   PubMed Web of Science ®Google Scholar
• Ji G, Lv K, Chen H, et al. MiR-146a regulates SOD2 expression in H2O2 stimulated PC12 cells. PLoS One. 2013;8:e69351doi: 10.1371/journal.pone.0069351.
   Google Scholar
• Efrati S, Berman S, Hamad RA, et al. Effect of captopril treatment on recuperation from ischemia/reperfusion-induced acute renal injury. Nephrol Dial Transplant. 2012;27:136–145.
   PubMed Web of Science ®Google Scholar
• Tawfik MK. Renoprotective activity of telmisartan versus pioglitazone on ischemia/reperfusion induced renal damage in diabetic rats. Eur Rev Med Pharmacol Sci. 2012;16:600–609.
   PubMed Web of Science ®Google Scholar
• Prathab Balaji S, Vijay Chand C, Justin A, Ramanathan M. Telmisartan mediates anti-inflammatory and not cognitive function through PPAR-γ agonism via SARM and MyD88 signaling. Pharmacol Biochem Behav. 2015;137:60–68.
   PubMed Web of Science ®Google Scholar
• Andersson P, Cederholm T, Johansson AS, Palmblad J. Captopril-impaired production of tumor necrosis factor-alpha-induced interleukin-1beta in human monocytes is associated with altered intracellular distribution of nuclear factor-kappaB. J Lab Clin Med. 2002;140:103–109.
   PubMed Web of Science ®Google Scholar